Scaling-up production of lentiviral vectors (LV)-based therapies is a persistent challenge for biomanufacturers, and one that threatens their development unless commercial-scale production ...
“By 2016, six out of ten of the blockbusters will be monoclonal-antibody-based therapeutics. With patent protection ending on many of these blockbusters by 2020 and this market estimated to be worth ...
Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Downstream Processing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's ...
(MENAFN- GlobeNewsWire - Nasdaq) The market is poised for growth (12.88% CAGR), driven by high demand for equipment due to capacity expansions, and the adoption of single-use systems, continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results